MECP2 and Neurodevelopmental delay: Another critical aspect of MECP2 in connection with miRNAs was recently described in patients with Down Syndrome (DS), a NDD characterized by cortical and cerebellar malformations and cognitive impairments (Patkee et al., 2020).